分类： health

The Emirates Drug Establishment (EDE) has announced an immediate recall of Hong Thai Herbal Inhaler (Yadom) from UAE markets due to confirmed microbial contamination in several batches. The decision follows laboratory tests that revealed contamination levels exceeding international safety standards for inhalation products. The affected batch, identified as 000332, was manufactured on December 9, 2024, and is set to expire on December 8, 2027. Approximately 200,000 units from this batch have been recalled in the UAE. The EDE has urged the public to cease using the product and safely dispose of any units they possess. Consumers experiencing symptoms such as shortness of breath, nasal irritation, or persistent dizziness after use are advised to seek medical attention. The recall is being coordinated with municipalities and regulatory authorities to ensure the product is removed from all points of sale, including online platforms. This action follows a similar recall in Thailand, where the product failed microbial contamination tests. Hong Thai, the manufacturer, has emphasized that customer safety remains their top priority.

In a concerted effort to combat cervical cancer, health experts are emphasizing the need to increase public awareness and dispel misconceptions surrounding the Human Papillomavirus (HPV) vaccine. HPV, the primary cause of cervical cancer, claimed nearly 350,000 lives globally in 2022, with China accounting for 16% of these fatalities. Starting Monday, China will integrate the HPV vaccine into its national immunization program, offering free bivalent vaccines to 13-year-old girls, administered in two doses six months apart. This initiative, announced by seven government agencies on October 30, aims to bolster public health and reduce cervical cancer rates. As of June, 18 provincial-level regions in China have already provided free HPV vaccinations to eligible girls, benefiting approximately 5 million annually, according to a State Council white paper released on September 19. In Beijing, for instance, seventh-grade girls are eligible for free domestically developed bivalent vaccines targeting HPV strains 16 and 18, which are responsible for 70-80% of cervical cancer cases. Despite these efforts, some parents remain hesitant. Li Yun, a Beijing mother, opted for an imported nine-valent vaccine for her daughter, citing reliability concerns. However, she noted that some parents declined the vaccine, citing fears of adverse effects or the belief that their children were too young to need it. Health experts like Tan Xianjie from Peking Union Medical College Hospital stress the importance of early vaccination, particularly before sexual activity begins, to maximize protection. The World Health Organization has set a global target to ensure 90% of girls receive full HPV vaccination by age 15 by 2030, as part of its strategy to eliminate cervical cancer. In China, the free vaccination policy has already made significant strides, covering many eligible girls and promoting health equity across the nation. Experts like Qiao Youlin from Peking Union Medical College and Zhao Fanghui from the National Cancer Center highlight the long-term benefits of vaccination and the need for continued public education to overcome hesitancy and ensure widespread uptake.

In a groundbreaking study, researchers from Lanzhou University have unveiled the heart-protective properties of nicotinamide, a derivative of B vitamins, in the context of tumor treatment. Published in the journal *Science China: Life Sciences*, the research sheds light on the mechanisms behind early cardiotoxicity induced by immune checkpoint inhibitors, such as anti-programmed cell death protein 1 (PD-1), which are increasingly used in cancer immunotherapy. Led by Professor Bai Ming of Lanzhou University First Hospital, the study combined clinical data with experimental models to explore the role of PD-1 in cardiotoxicity and its underlying pathways. The team conducted randomized controlled trials to validate nicotinamide’s efficacy in preventing early cardiotoxicity linked to PD-1 therapy. Their findings revealed that nicotinamide, a clinically accessible drug, offers a safe and effective preventive strategy. This approach emphasizes early intervention, enabling the protection of heart function without compromising anti-tumor efficacy. Professor Bai highlighted the significance of the study in addressing safety concerns in cancer treatment, noting that nicotinamide could serve as a promising preventive measure against cardiac immune-related adverse events. The research underscores the potential for rapid clinical application, offering a synergistic treatment model that balances tumor control and heart health.

Health experts are urging for heightened public awareness and the dispelling of misconceptions to improve the coverage rate of the human papillomavirus (HPV) vaccine in China. HPV, a leading cause of cervical cancer, claimed 350,000 lives globally in 2022, with China accounting for 16% of these fatalities. Starting November 10, China will integrate the HPV vaccine into its national immunization program, offering free bivalent HPV vaccines to girls aged 13 and above born after November 10, 2011. This marks a significant shift from previous policies that targeted children under six, now extending to adolescents and focusing on preventing a malignant tumor caused by chronic infection, particularly in women. Du Heng of the Gates Foundation emphasized the long-term impact of this initiative, noting that full outcomes may take 20 to 30 years to manifest. As of June, 18 provincial-level regions in China have already provided free HPV vaccinations to about 5 million girls annually, targeting those aged 9 to 14. In Beijing, for instance, girls in the 7th grade and above can receive free domestically developed bivalent vaccines, which protect against the two most common HPV strains responsible for 70-80% of cervical cancers. Despite these efforts, some parents remain hesitant, citing concerns about the necessity and safety of the vaccine. However, experts like Qiao Youlin from Peking Union Medical College believe that these challenges are temporary and will improve with increased health awareness. The World Health Organization aims for 90% of girls globally to be fully vaccinated against HPV by the age of 15 by 2030, as part of its strategy to eliminate cervical cancer. In China, the free vaccination policy has already covered many eligible girls, showcasing significant progress. Experts also stress the importance of regular cervical cancer screenings and the role of men in HPV prevention, as their infection rate is as high as 45%, often without symptoms. Eliminating cervical cancer is seen as a shared societal responsibility, achievable through enhanced scientific awareness and collective action.

NMC Royal Hospital located in Khalifa City has been honored with the esteemed Comprehensive Chest Pain Center Certification by the American Heart Association (AHA). This recognition underscores the hospital’s commitment to delivering exceptional cardiac care and its adherence to rigorous international standards in diagnosing and treating chest pain. The certification process involved a thorough evaluation of the hospital’s protocols, facilities, and medical expertise, ensuring that patients receive timely and effective care for cardiac emergencies. This achievement positions NMC Royal Hospital as a leader in cardiovascular health within the region, enhancing its reputation as a trusted healthcare provider. The certification also reflects the hospital’s dedication to continuous improvement and patient safety, aligning with global best practices in cardiac care.